‌

HemoShear Therapeutics, LLC SBIR Phase II Award, August 2017

A SBIR Phase II contract was awarded to Hemoshear Therapeutics in August, 2017 for $1,862,227.0 USD from the U.S. Department of Health & Human Services.

Overview Structured Data Issues Contributors

sbir.gov/node/1324429

Is a

SBIR/STTR Awards

SBIR/STTR Award attributes

SBIR/STTR Award Recipient

Hemoshear Therapeutics

Government Agency

Award Type

SBIR0

Contract Number (US Government)

1R44DK115301-010

Award Phase

Phase II0

Award Amount (USD)

1,862,2270

Date Awarded

August 1, 2017

End Date

January 31, 2020

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like HemoShear Therapeutics, LLC SBIR Phase II Award, August 2017

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API